<DOC>
	<DOCNO>NCT01319162</DOCNO>
	<brief_summary>Between 40 % 85 % woman Polycystic Ovary Syndrome ( PCOS ) overweight obese obesity closely link development PCOS . Although well establish obesity increase severity clinical feature PCOS , data regard prevalence PCOS obese woman change body weight woman PCOS time scare . In prevalence study investigate whether obesity increase risk PCOS general population demonstrate prevalence rate PCOS underweight , normal-weight , overweight , obese woman 8.2 , 9.8 , 9.9 , 9.0 % , respectively , similar observe general population . These result suggest risk PCOS minimally increase obesity . On hand , Spanish prevalence study among overweight obese subject , demonstrate 28.3 % prevalence PCOS , markedly high compare 5.5 % prevalence PCOS lean woman Spain . First investigator aim estimate prevalence/probability PCOS among obese , premenopausal woman ( 18 50 year ) symptoms classic menopausal symptom Sweden . Secondly , elucidate whether woman diagnose PCOS respond standard weight reduction regime extent woman without PCOS .</brief_summary>
	<brief_title>Prevalence Polycystic Ovary Syndrome ( PCOS ) Obese Premenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>PCOS diagnostic criterion presence clinical and/or biochemical hyperandrogenism and/or oligo/amenorrhea and/or polycystic ovary ( PCO ) . 1 . Exclusion endocrine disorder hyperprolactinemia ( sprolactin &lt; 27Âµg/L ) , nonclassic congenital adrenal hyperplasia ( 17hydroxyprogesterone &lt; 3nmol/L ) , androgen secreting tumor . 2 . Pregnancy breastfeed last 6 month . 3 . Any sign climacteric symptom . 4 . Language barrier disabled person reduce ability understand information . 5 . Oral contraceptive insulin sensitize agent commonly use among woman PCOS since may interfere hormone profile . As prevalence PCOS assume increase among woman use oral contraceptive insulin sensitize agent , include analyze separately .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PCOS</keyword>
</DOC>